Viewing Study NCT01750918


Ignite Creation Date: 2025-12-25 @ 4:31 AM
Ignite Modification Date: 2026-06-02 @ 10:33 AM
Study NCT ID: NCT01750918
Status: COMPLETED
Last Update Posted: 2021-10-29
First Post: 2012-12-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MEK inhibitor View
None anti-EGFR antibody View
None colorectal cancer View
None BRAF inhibitor View